Literature DB >> 19196711

Selectivity of docking sites in MAPK kinases.

A Jane Bardwell1, Erlynn Frankson, Lee Bardwell.   

Abstract

Protein kinases often recognize their substrates and regulators through docking interactions that occur outside of the active site; these interactions can help us to understand kinase networks, and to target kinases with drugs. During mitogen-activated protein kinase (MAPK) signaling, the ability of MAPK kinases (MKKs, or MEKs) to recognize their cognate MAPKs is facilitated by a short docking motif (the D-site) in the MKK N terminus, which binds to a complementary region on the MAPK. MAPKs then recognize many of their targets using the same strategy, because many MAPK substrates also contain D-sites. The extent to which docking contributes to the specificity of MAPK transactions is incompletely understood. Here we characterize the selectivity of the interaction between MKK-derived D-sites and MAPKs by measuring the ability of D-site peptides to inhibit MAPK-mediated phosphorylation of D-site-containing substrates. We find that all MKK D-sites bind better to their cognate MAPKs than they do to non-cognate MAPKs. For instance, the MKK3 D-site peptide, which is a remarkably potent inhibitor of p38alpha (IC(50) < 10 nm), does not inhibit JNK1 or JNK2. Likewise, MAPKs generally bind as well or better to cognate D-sites than to non-cognate D-sites. For instance, JNK1 and JNK2 do not appreciably bind to any D-sites other than their cognate D-sites from MKK4 and MKK7. In general, cognate, within-pathway interactions are preferred about an order of magnitude over non-cognate interactions. However, the selectivity of MAPKs and their cognate MKK-derived D-sites for each other is limited in some cases; in particular, ERK2 is not very selective. We conclude that MAPK-docking sites in MAPK kinases bind selectively to their cognate MAPKs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19196711      PMCID: PMC2676048          DOI: 10.1074/jbc.M900080200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  69 in total

1.  Proximity-induced catalysis by the protein kinase ERK2.

Authors:  Mark A Rainey; Kari Callaway; Richard Barnes; Brian Wilson; Kevin N Dalby
Journal:  J Am Chem Soc       Date:  2005-08-03       Impact factor: 15.419

Review 2.  The c-jun kinase/stress-activated pathway: regulation, function and role in human disease.

Authors:  Gary L Johnson; Kazuhiro Nakamura
Journal:  Biochim Biophys Acta       Date:  2007-01-04

Review 3.  MAP kinases and the control of nuclear events.

Authors:  A G Turjanski; J P Vaqué; J S Gutkind
Journal:  Oncogene       Date:  2007-05-14       Impact factor: 9.867

4.  Characterization of an ERK-binding domain in microphthalmia-associated transcription factor and differential inhibition of ERK2-mediated substrate phosphorylation.

Authors:  Douglas M Molina; Seema Grewal; Lee Bardwell
Journal:  J Biol Chem       Date:  2005-10-24       Impact factor: 5.157

Review 5.  Context-specific inhibition of JNKs: overcoming the dilemma of protection and damage.

Authors:  Vicki Waetzig; Thomas Herdegen
Journal:  Trends Pharmacol Sci       Date:  2005-09       Impact factor: 14.819

6.  Mitogen-activated protein kinase (MAPK)-docking sites in MAPK kinases function as tethers that are crucial for MAPK regulation in vivo.

Authors:  S Grewal; D M Molina; L Bardwell
Journal:  Cell Signal       Date:  2005-06-24       Impact factor: 4.315

Review 7.  Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer.

Authors:  P J Roberts; C J Der
Journal:  Oncogene       Date:  2007-05-14       Impact factor: 9.867

8.  Kinetic characterization of human JNK2alpha2 reaction mechanism using substrate competitive inhibitors.

Authors:  Linghao Niu; Kung-Ching Chang; Stacy Wilson; Patricia Tran; Fengrong Zuo; David C Swinney
Journal:  Biochemistry       Date:  2007-03-31       Impact factor: 3.162

Review 9.  Physiological roles of MKK4 and MKK7: insights from animal models.

Authors:  Xin Wang; Auriane Destrument; Cathy Tournier
Journal:  Biochim Biophys Acta       Date:  2006-11-10

10.  A novel mitogen-activated protein kinase docking site in the N terminus of MEK5alpha organizes the components of the extracellular signal-regulated kinase 5 signaling pathway.

Authors:  Jan Seyfried; Xin Wang; Giorgi Kharebava; Cathy Tournier
Journal:  Mol Cell Biol       Date:  2005-11       Impact factor: 4.272

View more
  65 in total

1.  Targeting diverse signaling interaction sites allows the rapid generation of bivalent kinase inhibitors.

Authors:  Zachary B Hill; B Gayani K Perera; Simeon S Andrews; Dustin J Maly
Journal:  ACS Chem Biol       Date:  2011-12-22       Impact factor: 5.100

Review 2.  New insights into the biological effects of anthrax toxins: linking cellular to organismal responses.

Authors:  Annabel Guichard; Victor Nizet; Ethan Bier
Journal:  Microbes Infect       Date:  2011-09-08       Impact factor: 2.700

Review 3.  Diversity in genetic in vivo methods for protein-protein interaction studies: from the yeast two-hybrid system to the mammalian split-luciferase system.

Authors:  Bram Stynen; Hélène Tournu; Jan Tavernier; Patrick Van Dijck
Journal:  Microbiol Mol Biol Rev       Date:  2012-06       Impact factor: 11.056

Review 4.  Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale.

Authors:  Beth A Rose; Thomas Force; Yibin Wang
Journal:  Physiol Rev       Date:  2010-10       Impact factor: 37.312

5.  Two hydrophobic residues can determine the specificity of mitogen-activated protein kinase docking interactions.

Authors:  A Jane Bardwell; Lee Bardwell
Journal:  J Biol Chem       Date:  2015-09-14       Impact factor: 5.157

Review 6.  Computational insights for the discovery of non-ATP competitive inhibitors of MAP kinases.

Authors:  Michael J Schnieders; Tamer S Kaoud; Chunli Yan; Kevin N Dalby; Pengyu Ren
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

7.  An Arabidopsis kinase cascade influences auxin-responsive cell expansion.

Authors:  Tara A Enders; Elizabeth M Frick; Lucia C Strader
Journal:  Plant J       Date:  2017-08-28       Impact factor: 6.417

Review 8.  Extracellular-Regulated Kinases: Signaling From Ras to ERK Substrates to Control Biological Outcomes.

Authors:  Scott T Eblen
Journal:  Adv Cancer Res       Date:  2018-03-02       Impact factor: 6.242

9.  A fluorescence-based assay for p38α recruitment site binders: identification of rooperol as a novel p38α kinase inhibitor.

Authors:  Jing Li; Tamer S Kaoud; Jake LeVieux; Brad Gilbreath; Swapna Moharana; Kevin N Dalby; Sean M Kerwin
Journal:  Chembiochem       Date:  2012-12-06       Impact factor: 3.164

10.  Epitope-guided engineering of monobody binders for in vivo inhibition of Erk-2 signaling.

Authors:  Jasdeep K Mann; Jordan F Wood; Anne Fleur Stephan; Emmanuel S Tzanakakis; Denise M Ferkey; Sheldon Park
Journal:  ACS Chem Biol       Date:  2012-12-18       Impact factor: 5.100

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.